Biochemical evaluation of the combination of Pegylated IFN-α2b and Ribavarin therapy of Egyptian patients suffering from Hepatitis C Virus
Hussein, S., EL Senosi, Y., El Barky, A., Al Fakharany, M. (2017). Biochemical evaluation of the combination of Pegylated IFN-α2b and Ribavarin therapy of Egyptian patients suffering from Hepatitis C Virus. EKB Journal Management System, 33(2), 9-16. doi: 10.21608/bvmj.2017.29983
Samy Ali Hussein; Yakout Abd EL Fatah EL Senosi; Amira Ragab El Barky; Mohamed Abdelkader Al Fakharany. "Biochemical evaluation of the combination of Pegylated IFN-α2b and Ribavarin therapy of Egyptian patients suffering from Hepatitis C Virus". EKB Journal Management System, 33, 2, 2017, 9-16. doi: 10.21608/bvmj.2017.29983
Hussein, S., EL Senosi, Y., El Barky, A., Al Fakharany, M. (2017). 'Biochemical evaluation of the combination of Pegylated IFN-α2b and Ribavarin therapy of Egyptian patients suffering from Hepatitis C Virus', EKB Journal Management System, 33(2), pp. 9-16. doi: 10.21608/bvmj.2017.29983
Hussein, S., EL Senosi, Y., El Barky, A., Al Fakharany, M. Biochemical evaluation of the combination of Pegylated IFN-α2b and Ribavarin therapy of Egyptian patients suffering from Hepatitis C Virus. EKB Journal Management System, 2017; 33(2): 9-16. doi: 10.21608/bvmj.2017.29983

Biochemical evaluation of the combination of Pegylated IFN-α2b and Ribavarin therapy of Egyptian patients suffering from Hepatitis C Virus

Benha Veterinary Medical Journal
Article 2, Volume 33, Issue 2, December 2017, Page 9-16  XML PDF (641.63 K)
Document Type: Original Article
DOI: 10.21608/bvmj.2017.29983
View on SCiNiTO View on SCiNiTO
Authors
Samy Ali Hussein1; Yakout Abd EL Fatah EL Senosi1; Amira Ragab El Barky2; Mohamed Abdelkader Al Fakharany2
1Department of Biochemistry, Faculty of Vet. Med., Benha University, Egypt.
2Department of Biochemistry, Faculty of Vet. Med., Benha University, Egypt
Abstract
The purpose of this study was to evaluate the biochemical parameters and cytokines levels in infected Egyptian patient.
This study was conducted on 32 patients. 25 of them were suffering from chronic HCV and the other 7 males are selfreported
healthy volunteers. They were classified as the following: Group I (control healthy group), Group II (HCV-non
treated group) Group III- Group VI (HCV-treated with 12,24,36,48 ampoule of interferon). The obtained results showed
a significant increase in the activities of serum liver marker enzymes ALT, AST and ALP, cytokines Il2, Il4 and Il10,
also a significant increase was observed in serum Ferritin and Alpha feto protein. On the other hand, a significant
decrease in both sera total protein and albumin level. Whereas administration of combination of Pegylated IFN-α2b and
Ribavarin significantly improved the alert in the biochemical parameters. These results suggested that, combination
therapy of both peg-interferon and ribavirin, emphasizing the influence of these compounds for patient with HCV,
possibly preventing alteration of enzymes of liver activities. Because peg-interferon treatment can reduce liver injury
and anti-inflammatory effect, as well as by decreasing plasma cytokine as cytokines, is present in patients with HCV
liver disease. Furthermore, treatment with IFN-α diminishes the Th2 cytokine response. Thus, modulation of T- cell
function and cytokine production may be one mechanism whereby IFN-α therapy results in reduced viral burden
Keywords
Hepatitis C virus; Cytokines; TNF-α; IgG and total protein
Statistics
Article View: 101
PDF Download: 293